Unknown

Dataset Information

0

Purification, characterization, and immunogenicity of the refolded ectodomain of the Plasmodium falciparum apical membrane antigen 1 expressed in Escherichia coli.


ABSTRACT: The apical membrane antigen 1 (AMA1) has emerged as a promising vaccine candidate against malaria. Advanced evaluation of its protective efficacy in humans requires the production of highly purified and correctly folded protein. We describe here a process for the expression, fermentation, refolding, and purification of the recombinant ectodomain of AMA1 (amino acids 83(Gly) to 531(Glu)) of Plasmodium falciparum (3D7) produced in Escherichia coli. A synthetic gene containing an E. coli codon bias was cloned into a modified pET32 plasmid, and the recombinant protein was produced by using a redox-modified E. coli strain, Origami (DE3). A purification process was developed that included Sarkosyl extraction followed by affinity purification on a Ni-nitrilotriacetic acid column. The recombinant AMA1 was refolded in the presence of reduced and oxidized glutathione and further purified by using two ion-exchange chromatographic steps. The final product, designated AMA1/E, was homogeneous, monomeric, and >99% pure and had low endotoxin content and low host cell contamination. Analysis of AMA1/E showed that it had the predicted primary sequence, and tertiary structure analysis confirmed its compact disulfide-bonded nature. Rabbit antibodies made to the protein recognized the native parasite AMA1 and inhibited the growth of the P. falciparum homologous 3D7 clone in an in vitro assay. Reduction-sensitive epitopes on AMA1/E were shown to be necessary for the production of inhibitory anti-AMA1 antibodies. AMA1/E was recognized by a conformation-dependent, growth-inhibitory monoclonal antibody, 4G2dc1. The process described here was successfully scaled up to produce AMA1/E protein under GMP conditions, and the product was found to induce highly inhibitory antibodies in rabbits.

SUBMITTER: Dutta S 

PROVIDER: S-EPMC127972 | biostudies-literature | 2002 Jun

REPOSITORIES: biostudies-literature

altmetric image

Publications

Purification, characterization, and immunogenicity of the refolded ectodomain of the Plasmodium falciparum apical membrane antigen 1 expressed in Escherichia coli.

Dutta Sheetij S   Lalitha P V PV   Ware Lisa A LA   Barbosa Arnoldo A   Moch J Kathleen JK   Vassell Meredith A MA   Fileta Bader B BB   Kitov Svetlana S   Kolodny Nelly N   Heppner D Gray DG   Haynes J David JD   Lanar David E DE  

Infection and immunity 20020601 6


The apical membrane antigen 1 (AMA1) has emerged as a promising vaccine candidate against malaria. Advanced evaluation of its protective efficacy in humans requires the production of highly purified and correctly folded protein. We describe here a process for the expression, fermentation, refolding, and purification of the recombinant ectodomain of AMA1 (amino acids 83(Gly) to 531(Glu)) of Plasmodium falciparum (3D7) produced in Escherichia coli. A synthetic gene containing an E. coli codon bias  ...[more]

Similar Datasets

| S-EPMC470679 | biostudies-literature
| S-EPMC1218507 | biostudies-other
| S-EPMC308882 | biostudies-literature
| S-EPMC5006270 | biostudies-literature
| S-EPMC1461755 | biostudies-other
| S-EPMC1230972 | biostudies-literature
| S-EPMC2213267 | biostudies-literature
| S-EPMC3648006 | biostudies-literature
| S-EPMC3046304 | biostudies-literature
| S-EPMC556269 | biostudies-literature